
Hui Yang
Articles
-
Dec 28, 2024 |
mdpi.com | Hui Yang
This is an early access version, the complete PDF, HTML, and XML versions will be available soon.
-
Dec 12, 2024 |
nature.com | Hui Yang
AbstractDuplication of methyl-CpG-binding protein 2 (MECP2) gene causes MECP2 duplication syndrome (MDS). To normalize the duplicated MECP2 in MDS, we developed a high-fidelity Cas13Y (hfCas13Y) system capable of targeting the MECP2 (hfCas13Y-gMECP2) messenger RNA for degradation and reducing protein levels in the brain of humanized MECP2 transgenic mice.
-
Nov 19, 2024 |
nature.com | Wei Zhu |Wei Hua |Hui Yang
AbstractGliomas exhibit high heterogeneity and poor prognosis. Despite substantial progress has been made at the genomic and transcriptomic levels, comprehensive proteomic characterization and its implications remain largely unexplored. In this study, we perform proteomic profiling of gliomas using 343 formalin-fixed and paraffin-embedded tumor samples and 53 normal-appearing brain samples from 188 patients, integrating these data with genomic panel information and clinical outcomes.
-
Nov 18, 2024 |
onlinelibrary.wiley.com | Hongyu Chu |Yanni Li |Hui Yang |Yuhang LIU
European Association for the Study of the Liver. Electronic Address: [email protected], European Association for the Study of the LiverEASL Clinical Practice Guidelines: The Diagnosis and Management of Patients With Primary Biliary Cholangitis
-
Sep 30, 2024 |
mdpi.com | Hui Yang |Qing Sun |Jiaxin Yuan
This is an early access version, the complete PDF, HTML, and XML versions will be available soon. Open AccessArticle by Hui Yang SciProfiles Scilit Preprints.org Google Scholar , Qing Sun SciProfiles Scilit Preprints.org Google Scholar and Jiaxin Yuan SciProfiles Scilit Preprints.org Google Scholar * College of Air Transportation, Shanghai University of Engineering Science, Shanghai 201620, China *Author to whom correspondence should be addressed.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →